Logo image
IRO Home Research units Researcher Profiles
Sign in
Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient
Journal article   Peer reviewed

Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient

Kongkiat Chaikriangkrai, Rajiv Goswami, Stephen Little, Su Min Chang, Basal Ramlawi, Hye Yeon Jhun, Neal Kleiman, Michael J Reardon and Colin Barker
Journal of cardiac surgery, Vol.30(9), pp.697-700
09/2015
DOI: 10.1111/jocs.12604
PMID: 26228701

View Online

Abstract

Transcatheter mitral valve-in-valve implantation (TMVIV) is an option for patients with mitral prosthetic valve dysfunction who are at high risk for surgical valve replacement. Efficacy and safety of TMVIV is at its infancy. We report a high-risk symptomatic dialysis-dependent end-stage renal disease patient with severe bioprosthetic mitral valve stenosis who had TMVIV performed successfully.
Severity of Illness Index Humans Middle Aged Heart Valve Prosthesis Implantation - methods Bioprosthesis Male Mitral Valve - surgery Risk Treatment Outcome Mitral Valve Stenosis - surgery Kidney Failure, Chronic - complications Dialysis Mitral Valve Stenosis - etiology

Details

Metrics

Logo image